Chronic obstructive pulmonary disease (COPD) remains a major public health problem. It is
the fourth leading cause of chronic morbidity and mortality in the United States, and is …

… (1.1C warming) to 30% (6.4C warming) of the 3349 species studied (72). A global assessment
of expected warming-induced range contractions estimated that 184 to 327 montane bird …

… However, this therapy is very expensive, is not available in most countries, and is not
recommended for COPD that is not related to α 1 -antitrypsin deficiency (Evidence C). … In …

Background Long-acting beta-agonists and inhaled corticosteroids are used to treat chronic
obstructive pulmonary disease (COPD), but their effect on survival is unknown. Methods We …

… (A to C) For each fragmentation treatment [reduced area in BDFFP, Wog Wog, Kansas (A);
increased isolation in SRS and Moss (B); and increased edge in all experiments (C)], we …

We conducted a multicenter randomized double-blind clinical trial among 626 men with mild
to moderate hypertension to determine the effects of captopril, methyldopa, and propranolol …

Clinical coronary heart disease (CHD) occurred in 257 subjects during eight to nine years of
follow-up (average, 8 1/2 years) in a prospective study of 39- to 59-year-old employed men. …

Identifying priority areas for biodiversity is essential for directing conservation resources.
Fundamentally, we must know where individual species live, which ones are vulnerable, where …

Problems in sleeping are widely prevalent in modern society and are often one of the
presenting complaints of patients consulting physicians. In addition, there is scattered …

Rationale: Chronic obstructive pulmonary disease (COPD) is characterized by an accelerated
decline in lung function. No drug has been shown conclusively to reduce this decline. …